G20 India 2023 – Meril Life Sciences Shaping the Future with Technology Innovation and R&D

In the realm of technological innovation, the transformative potential is undeniable. It's a driving force for economic growth, a critical tool in combating climate change and promoting social inclusion. The spark of innovation often comes from the passion and drive of tech entrepreneurs and startups, who bring groundbreaking ideas to market, creating jobs and fostering economic growth. To further fuel this innovative ecosystem, it is crucial to spread awareness of the manifold benefits that technology can offer.

In this blog, we delve into our participation in the 'Compendium of Best Practices on Innovation Projects,' featuring not only our journey but a wealth of insights from innovators across India and other B20 Nations who share our commitment to driving progress through technology.

Neurovascular devices

Currently, India relies heavily on imports of neurovascular products. The cost of neurovascular devices in India ranges from 50,000 INR (625 US dollars) to one million INR (12500 US dollars). Once indigenous devices are available, prices are expected to drop by 40–50%.

The biggest challenge lies in the size, especially the diameter. India has been producing a large number of implants for bones that are larger in size, and for arteries that are smaller in size, such as cardiacstents, peripheral stents, and so on. In the case of neuroimplants, especially those for the brain, where the diameters are just a few microns.

Therefore, very high accuracy and precision and a totally different research approach are required. During the development of neurovascular Implants, balloon catheters, microcatheters, and related accessories, from the raw materials to various processes like Braiding, Laser Cutting, Electro-Polishing, Heat Setting, Chemical Passivation, Delivery System Assembly, and Sterilisation, etc. The biggest challenge was achieving consistency for the desired level of precision in neuroimplants. This was especially difficult as all implants are very miniature, soft, and flexible due to the target location and critical clinical cases.

Project impact

Meril gradually developed various technologies to make products and implants specifically for neurovascular applications. We have completed development work and have recently received DCGI approval for three neurodevices:

• Flow Diverter: Meril’s brand, Silk Route, for the treatment of Aneurism.
• Clot Retrieval Device: Meril’s Brand, Restora, to remove clots from the neurovascular artery.
• Neurovascular Coil: Meril’s Brand, EmboNest, is also used to treat aneurisms.

 

Check the Compendium of Best Practices on Innovation Projects from India and other B20 Nations here.